Skip to content
drillr.ai

KRMD

KORU Medical Systems, Inc.

NASDAQ · USHealthcareMedical - Instruments & Supplies
$4.06-1.22%

Price as of Jul 20, 2026

KRMD news

KORU Medical Systems, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. KORU Medical Systems Announces CEO Transition

    KORU Medical Systems Announces CEO Transition Linda Tharby to Retire after Five Years of Transformational Leadership; Adam Kalbermatten Appointed CEO, effective July 1, 2026 KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that following five years of service to the Company

    Business Wire ·

  2. KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance

    KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 202

    Business Wire ·

  3. KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    For best results when printing this announcement, please click on link below: https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nBw4Dp1l0a&default-theme=true KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-c

    Business Wire ·